The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour

Acta Physiologica

Volumn 213, Issue 3, 2015, Pages 603-627

  Farzi, A ^a   Reichmann, F ^a   Holzer, P ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Brain; Immune system; Neuropeptide Y

Indexed keywords

NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y4 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; NEUROPEPTIDE Y RECEPTOR;

BEHAVIOR; BEHAVIOR DISORDER; CYTOKINE RELEASE; DENDRITIC CELL; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; LYMPHOCYTE; MACROPHAGE; MICROGLIA; MONOCYTE; MOOD; NONHUMAN; PRIORITY JOURNAL; REVIEW; AFFECT; ANIMAL; BRAIN; EMOTION; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; MENTAL STRESS; METABOLISM; OBESITY; SIGNAL TRANSDUCTION;

AFFECT; ANIMALS; BEHAVIOR; BRAIN; EMOTIONS; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEUROPEPTIDE Y; OBESITY; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL;

EID: 84921484016     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12445     Document Type: Review

References (235)

1. 3-35: a new peptide generated by plasma kallikrein. J Biol Chem 284, 24715-24724.
2. Adrian, T.E., Savage, A.P., Bacarese-Hamilton, A.J., Wolfe, K., Besterman, H.S. & Bloom, S.R. 1986. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90, 379-384.
3. Ahlborg, G., Weitzberg, E., Sollevi, A. & Lundberg, J.M. 1992. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man. Acta Physiol Scand 145, 139-149.
4. Ahmed, A.A., Wahbi, A., Nordlind, K., Kharazmi, A., Sundqvist, K.G., Mutt, V. & Liden, S. 1998. In vitro Leishmania major promastigote-induced macrophage migration is modulated by sensory and autonomic neuropeptides. Scand J Immunol 48, 79-85.
5. Ahmed, A.A., Wahbi, A.H. & Nordlin, K. 2001. Neuropeptides modulate a murine monocyte/macrophage cell line capacity for phagocytosis and killing of Leishmania major parasites. Immunopharmacol Immunotoxicol 23, 397-409.
6. Alexander, S.P., Mathie, A. & Peters, J.A. 2011. Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 164(Suppl 1), S1-S324.
7. Allen, Y.S., Adrian, T.E., Allen, J.M., Tatemoto, K., Crow, T.J., Bloom, S.R. & Polak, J.M. 1983. Neuropeptide Y distribution in the rat brain. Science 221, 877-879.
8. Augustyniak, D., Jankowski, A., Mackiewicz, P., Skowyra, A., Gutowicz, J. & Drulis-Kawa, Z. 2012. Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae. BMC Immunol 13, 24.
9. Baker, D.G., Bertram, T.M., Patel, P.M., Barkauskas, D.A., Clopton, P., Patel, S., Geracioti, T.D. Jr, Haji, U., O'Connor, D.T., Nievergelt, C.M. & Hauger, R.L. 2013. Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe. Psychoneuroendocrinology 38, 2378-2382.
10. Bannon, A.W., Seda, J., Carmouche, M., Francis, J.M., Norman, M.H., Karbon, B. & McCaleb, M.L. 2000. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868, 79-87.
11. Bär, F., Foh, B., Pagel, R., Schroder, T., Schlichting, H., Hirose, M., Lemcke, S., Klinger, A., Konig, P., Karsten, C.M., Buning, J., Lehnert, H., Fellermann, K., Ibrahim, S.M. & Sina, C. 2014. Carboxypeptidase E modulates intestinal immune homeostasis and protects against experimental colitis in mice. PLoS One 9, e102347.
12. Baticic, L., Detel, D., Kucic, N., Buljevic, S., Pugel, E.P. & Varljen, J. 2011. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice. J Cell Biochem 112, 3322-3333.
13. Bedoui, S., Kuhlmann, S., Nave, H., Drube, J., Pabst, R. & von Horsten, S. 2001. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J Neuroimmunol 117, 125-132.
14. Bedoui, S., Lechner, S., Gebhardt, T., Nave, H., Beck-Sickinger, A.G., Straub, R.H., Pabst, R. & von Horsten, S. 2002. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J Neuroimmunol 132, 25-33.
15. Bedoui, S., Miyake, S., Lin, Y., Miyamoto, K., Oki, S., Kawamura, N., Beck-Sickinger, A., von Horsten, S. & Yamamura, T. 2003. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J Immunol 171, 3451-3458.
16. Bedoui, S., von Horsten, S. & Gebhardt, T. 2007. A role for neuropeptide Y (NPY) in phagocytosis: implications for innate and adaptive immunity. Peptides 28, 373-376.
17. Bedoui, S., Kromer, A., Gebhardt, T., Jacobs, R., Raber, K., Dimitrijevic, M., Heine, J. & von Horsten, S. 2008. Neuropeptide Y receptor-specifically modulates human neutrophil function. J Neuroimmunol 195, 88-95.
18. Bellavance, M.A. & Rivest, S. 2014. The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain. Front Immunol 5, 136.
19. Boey, D., Lin, S., Karl, T., Baldock, P., Lee, N., Enriquez, R., Couzens, M., Slack, K., Dallmann, R., Sainsbury, A. & Herzog, H. 2006. Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49, 1360-1370.
20. Böttcher, G., Ekblad, E., Ekman, R., Hakanson, R. & Sundler, F. 1993. Peptide YY: a neuropeptide in the gut. Immunocytochemical and immunochemical evidence. Neuroscience 55, 281-290.
21. Broberger, C., Visser, T.J., Kuhar, M.J. & Hokfelt, T. 1999. Neuropeptide Y innervation and neuropeptide-Y-Y1-receptor-expressing neurons in the paraventricular hypothalamic nucleus of the mouse. Neuroendocrinology 70, 295-305.
22. Brod, S.A. & Bauer, V.L. 2012. Ingested (oral) neuropeptide Y inhibits EAE. J Neuroimmunol 250, 44-49.
23. Brumovsky, P., Shi, T.S., Landry, M., Villar, M.J. & Hokfelt, T. 2007. Neuropeptide tyrosine and pain. Trends Pharmacol Sci 28, 93-102.
24. Buttari, B., Profumo, E., Domenici, G., Tagliani, A., Ippoliti, F., Bonini, S., Businaro, R., Elenkov, I. & Rigano, R. 2014. Neuropeptide Y induces potent migration of human immature dendritic cells and promotes a Th2 polarization. FASEB J 28, 3038-3049.
25. Caberlotto, L., Fuxe, K. & Hurd, Y.L. 2000. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 20, 327-337.
26. Cani, P.D. & Delzenne, N.M. 2011. The gut microbiome as therapeutic target. Pharmacol Ther 130, 202-212.
27. Cani, P.D., Lecourt, E., Dewulf, E.M., Sohet, F.M., Pachikian, B.D., Naslain, D., De Backer, F., Neyrinck, A.M. & Delzenne, N.M. 2009. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236-1243.
28. Carlson, D.E., Le, W., Chiu, W.C. & Hoffman, G.E. 2009. Messenger RNA for neuropeptide Y in the arcuate nucleus increases in parallel with plasma adrenocorticotropin during sepsis in the rat. Neurosci Lett 452, 146-150.
29. Cerda-Reverter, J.M. & Larhammar, D. 2000. Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution. Biochem Cell Biol 78, 371-392.
30. Chandarana, K., Gelegen, C., Irvine, E.E., Choudhury, A.I., Amouyal, C., Andreelli, F., Withers, D.J. & Batterham, R.L. 2013. Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance. Mol Metab 2, 142-152.
31. Chandrasekharan, B., Bala, V., Kolachala, V.L., Vijay-Kumar, M., Jones, D., Gewirtz, A.T., Sitaraman, S.V. & Srinivasan, S. 2008. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One 3, e3304.
32. Chandrasekharan, B., Jeppsson, S., Pienkowski, S., Belsham, D.D., Sitaraman, S.V., Merlin, D., Kokkotou, E., Nusrat, A., Tansey, M.G. & Srinivasan, S. 2013a. Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility. Inflamm Bowel Dis 19, 2535-2546.
33. Chandrasekharan, B., Nezami, B.G. & Srinivasan, S. 2013b. Emerging neuropeptide targets in inflammation: NPY and VIP. Am J Physiol Gastrointest Liver Physiol 304, G949-G957.
34. Cherbut, C., Ferrier, L., Roze, C., Anini, Y., Blottiere, H., Lecannu, G. & Galmiche, J.P. 1998. Short-chain fatty acids modify colonic motility through nerves and polypeptide YY release in the rat. Am J Physiol 275, G1415-G1422.
35. Cohen, H., Liu, T., Kozlovsky, N., Kaplan, Z., Zohar, J. & Mathe, A.A. 2012. The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 37, 350-363.
36. Cox, H.M. 2007a. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton Neurosci 133, 76-85.
37. Cox, H.M. 2007b. Peptide YY: a neuroendocrine neighbor of note. Peptides 28, 345-351.
38. Czerniawski, J. & Guzowski, J.F. 2014. Acute neuroinflammation impairs context discrimination memory and disrupts pattern separation processes in hippocampus. J Neurosci 34, 12470-12480.
39. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W. & Kelley, K.W. 2008. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9, 46-56.
40. De la Fuente, M., Bernaez, I., Del Rio, M. & Hernanz, A. 1993. Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 80, 259-265.
41. De la Fuente, M., Medina, S., Del Rio, M., Ferrandez, M.D. & Hernanz, A. 2000. Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci 67, 2125-2135.
42. De la Fuente, M., Del Rio, M. & Medina, S. 2001a. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116, 156-167.
43. De la Fuente, M., Del Rio, M., Victor, V.M. & Medina, S. 2001b. Neuropeptide Y effects on murine natural killer activity: changes with ageing and cAMP involvement. Regul Pept 101, 73-79.
44. de Lange, R.P., Wiegant, V.M. & Stam, R. 2008. Altered neuropeptide Y and neurokinin messenger RNA expression and receptor binding in stress-sensitised rats. Brain Res 1212, 35-47.
45. Decressac, M., Wright, B., David, B., Tyers, P., Jaber, M., Barker, R.A. & Gaillard, A. 2011. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus 21, 233-238.
46. Delzenne, N.M., Neyrinck, A.M., Backhed, F. & Cani, P.D. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 7, 639-646.
47. DiMaggio, D.A., Chronwall, B.M., Buchanan, K. & O'Donohue, T.L. 1985. Pancreatic polypeptide immunoreactivity in rat brain is actually neuropeptide Y. Neuroscience 15, 1149-1157.
48. Dimitrijevic, M. & Stanojevic, S. 2013. The intriguing mission of neuropeptide Y in the immune system. Amino Acids 45, 41-53.
49. Dimitrijevic, M., Stanojevic, S., Vujic, V., Kovacevic-Jovanovic, V., Beck-Sickinger, A., Demuth, H. & von Horsten, S. 2002. Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26). J Neuroimmunol 129, 35-42.
50. Dimitrijevic, M., Stanojevic, S., Vujic, V., Beck-Sickinger, A. & von Horsten, S. 2005. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors. Regul Pept 124, 163-172.
51. Dimitrijevic, M., Stanojevic, S., Micic, S., Vujic, V., Kovacevic-Jovanovic, V., Mitic, K., von Horsten, S. & Kosec, D. 2006. Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch. Peptides 27, 3208-3215.
52. Dimitrijevic, M., Stanojevic, S., Mitic, K., Kustrimovic, N., Vujic, V., Miletic, T. & Kovacevic-Jovanovic, V. 2008. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides 29, 2179-2187.
53. Dimitrijevic, M., Stanojevic, S., Mitic, K., Kustrimovic, N., Vujic, V., Miletic, T. & Kovacevic-Jovanovic, V. 2010. Modulation of granulocyte functions by peptide YY in the rat: age-related differences in Y receptors expression and plasma dipeptidyl peptidase 4 activity. Regul Pept 159, 100-109.
54. Dimitrijevic, M., Mitic, K., Kustrimovic, N., Vujic, V. & Stanojevic, S. 2012. NPY suppressed development of experimental autoimmune encephalomyelitis in Dark Agouti rats by disrupting costimulatory molecule interactions. J Neuroimmunol 245, 23-31.
55. Domschke, K., Dannlowski, U., Hohoff, C., Ohrmann, P., Bauer, J., Kugel, H., Zwanzger, P., Heindel, W., Deckert, J., Arolt, V., Suslow, T. & Baune, B.T. 2010. Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20, 301-309.
56. Du, M., Butchi, N.B., Woods, T., Morgan, T.W. & Peterson, K.E. 2010. Neuropeptide Y has a protective role during murine retrovirus-induced neurological disease. J Virol 84, 11076-11088.
57. Dureus, P., Louis, D., Grant, A.V., Bilfinger, T.V. & Stefano, G.B. 1993. Neuropeptide Y inhibits human and invertebrate immunocyte chemotaxis, chemokinesis, and spontaneous activation. Cell Mol Neurobiol 13, 541-546.
58. Dwivedi, M., Laddha, N.C., Shah, K., Shah, B.J. & Begum, R. 2013. Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo. J Interferon Cytokine Res 33, 646-659.
59. Eaton, K., Sallee, F.R. & Sah, R. 2007. Relevance of neuropeptide Y (NPY) in psychiatry. Curr Top Med Chem 7, 1645-1659.
60. Edelsbrunner, M.E., Herzog, H. & Holzer, P. 2009a. Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res 203, 97-107.
61. Edelsbrunner, M.E., Painsipp, E., Herzog, H. & Holzer, P. 2009b. Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake. Neuropeptides 43, 491-497.
62. Ekblad, E. & Sundler, F. 2002. Distribution of pancreatic polypeptide and peptide YY. Peptides 23, 251-261.
63. El Karim, I.A., Linden, G.J., Orr, D.F. & Lundy, F.T. 2008. Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites. J Neuroimmunol 200, 11-16.
64. El-Salhy, M., Danielsson, A., Stenling, R. & Grimelius, L. 1997. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 242, 413-419.
65. Farzi, A., Reichmann, F., Meinitzer, A., Mayerhofer, R., Jain, P., Hassan, A.M., Frohlich, E.E., Wagner, K., Painsipp, E., Rinner, B. & Holzer, P. 2015. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers. Brain Behav Immun 44, 106-120.
66. Felies, M., von Horsten, S., Pabst, R. & Nave, H. 2004. Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats. J Physiol 561, 245-252.
67. Ferreira, R., Xapelli, S., Santos, T., Silva, A.P., Cristovao, A., Cortes, L. & Malva, J.O. 2010. Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J Biol Chem 285, 41921-41934.
68. Ferreira, R., Santos, T., Viegas, M., Cortes, L., Bernardino, L., Vieira, O.V. & Malva, J.O. 2011. Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells. J Neuroinflammation 8, 169.
69. Ferreira, R., Santos, T., Cortes, L., Cochaud, S., Agasse, F., Silva, A.P., Xapelli, S. & Malva, J.O. 2012. Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility. J Neurochem 120, 93-105.
70. Field, B.C., Chaudhri, O.B. & Bloom, S.R. 2010. Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol 6, 444-453.
71. Flood, J.F., Hernandez, E.N. & Morley, J.E. 1987. Modulation of memory processing by neuropeptide Y. Brain Res 421, 280-290.
72. Forbes, S., Herzog, H. & Cox, H.M. 2012. A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress. Br J Pharmacol 166, 2307-2316.
73. Fu-Cheng, X., Anini, Y., Chariot, J., Castex, N., Galmiche, J.P. & Roze, C. 1997. Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut. Pflugers Arch 433, 571-579.
74. Fujimiya, M. & Inui, A. 2000. Peptidergic regulation of gastrointestinal motility in rodents. Peptides 21, 1565-1582.
75. Gayle, D., Ilyin, S.E. & Plata-Salaman, C.R. 1997. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res Bull 44, 311-317.
76. Gayle, D., Ilyin, S.E., Flynn, M.C. & Plata-Salaman, C.R. 1998. Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Res 795, 77-86.
77. Gayle, D., Ilyin, S.E. & Plata-Salaman, C.R. 1999. Feeding status and bacterial LPS-induced cytokine and neuropeptide gene expression in hypothalamus. Am J Physiol 277, R1188-R1195.
78. Gelegen, C., Chandarana, K., Choudhury, A.I., Al-Qassab, H., Evans, I.M., Irvine, E.E., Hyde, C.B., Claret, M., Andreelli, F., Sloan, S.E., Leiter, A.B., Withers, D.J. & Batterham, R.L. 2012. Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in mice. Am J Physiol Endocrinol Metab 303, E659-E668.
79. Ghia, J.E., Blennerhassett, P., Deng, Y., Verdu, E.F., Khan, W.I. & Collins, S.M. 2009. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 136, 2280-2288.e1-4.
80. Goldberg, Y., Taimor, G., Piper, H.M. & Schluter, K.D. 1998. Intracellular signaling leads to the hypertrophic effect of neuropeptide Y. Am J Physiol 275, C1207-C1215.
81. Greco, B. & Carli, M. 2006. Reduced attention and increased impulsivity in mice lacking NPY Y2 receptors: relation to anxiolytic-like phenotype. Behav Brain Res 169, 325-334.
82. Gregor, M.F. & Hotamisligil, G.S. 2011. Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445.
83. Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R. & Van Immerseel, F. 2010. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 23, 366-384.
84. Hallden, G. & Aponte, G.W. 1997. Evidence for a role of the gut hormone PYY in the regulation of intestinal fatty acid-binding protein transcripts in differentiated subpopulations of intestinal epithelial cell hybrids. J Biol Chem 272, 12591-12600.
85. Hamer, H.M., Jonkers, D., Venema, K., Vanhoutvin, S., Troost, F.J. & Brummer, R.J. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119.
86. Hansel, D.E., Eipper, B.A. & Ronnett, G.V. 2001. Neuropeptide Y functions as a neuroproliferative factor. Nature 410, 940-944.
87. Haroon, E., Raison, C.L. & Miller, A.H. 2012. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37, 137-162.
88. Hassan, A.M., Jain, P., Reichmann, F., Mayerhofer, R., Farzi, A., Schuligoi, R. & Holzer, P. 2014. Repeated predictable stress causes resilience against colitis-induced behavioral changes in mice. Front Behav Neurosci 8, 386.
89. Hassani, H., Lucas, G., Rozell, B. & Ernfors, P. 2005. Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am J Physiol Gastrointest Liver Physiol 288, G550-G556.
90. Hauser, G.J., Myers, A.K., Dayao, E.K. & Zukowska-Grojec, Z. 1993. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. Am J Physiol 265, H1416-H1423.
91. Hauser, G.J., Dayao, E.K. & Zukowska-Grojec, Z. 1995. Effect of neuropeptide Y on endotoxin-induced suppression of the response to various agonists in conscious rats. Life Sci 57, 235-244.
92. Heilig, M. 2004. The NPY system in stress, anxiety and depression. Neuropeptides 38, 213-224.
93. Heilig, M., Koob, G.F., Ekman, R. & Britton, K.T. 1994. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17, 80-85.
94. Hernanz, A., Tato, E., De la Fuente, M., de Miguel, E. & Arnalich, F. 1996. Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects. J Neuroimmunol 71, 25-30.
95. Herzog, H. 2003. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480, 21-29.
96. Herzog, H., Hort, Y.J., Ball, H.J., Hayes, G., Shine, J. & Selbie, L.A. 1992. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89, 5794-5798.
97. Hirotani, Y., Mikajiri, K., Ikeda, K., Myotoku, M. & Kurokawa, N. 2008. Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone. Yakugaku Zasshi 128, 1347-1353.
98. Hirsch, D. & Zukowska, Z. 2012. NPY and stress 30 years later: the peripheral view. Cell Mol Neurobiol 32, 645-659.
99. Holzer, P. & Farzi, A. 2014. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 817, 195-219.
100. Holzer, P., Bartho, L., Lippe, I.T., Petritsch, W. & Leb, G. 1986. Effect of pancreatic polypeptide on the motility of the guinea-pig small intestine in vitro. Regul Pept 16, 305-314.
101. Holzer, P., Lippe, I.T., Bartho, L. & Saria, A. 1987. Neuropeptide Y inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. Gastroenterology 92, 1944-1950.
102. Holzer, P., Reichmann, F. & Farzi, A. 2012. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides 46, 261-274.
103. Holzer-Petsche, U., Petritsch, W., Hinterleitner, T., Eherer, A., Sperk, G. & Krejs, G.J. 1991. Effect of neuropeptide Y on jejunal water and ion transport in humans. Gastroenterology 101, 325-330.
104. Ilyin, S.E., Gayle, D., Flynn, M.C. & Plata-Salaman, C.R. 1998. Interleukin-1beta system (ligand, receptor type I, receptor accessory protein and receptor antagonist), TNF-alpha, TGF-beta1 and neuropeptide Y mRNAs in specific brain regions during bacterial LPS-induced anorexia. Brain Res Bull 45, 507-515.
105. Imaki, T., Shibasaki, T., Chikada, N., Harada, S., Naruse, M. & Demura, H. 1996. Different expression of immediate-early genes in the rat paraventricular nucleus induced by stress: relation to corticotropin-releasing factor gene transcription. Endocr J 43, 629-638.
106. Imran, M., Laddha, N.C., Dwivedi, M., Mansuri, M.S., Singh, J., Rani, R., Gokhale, R.S., Sharma, V.K., Marfatia, Y.S. & Begum, R. 2012. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo. Br J Dermatol 167, 314-323.
107. Irwin, M., Brown, M., Patterson, T., Hauger, R., Mascovich, A. & Grant, I. 1991. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J 5, 3100-3107.
108. Iwasa, T., Matsuzaki, T., Kinouchi, R., Fujisawa, S., Murakami, M., Kiyokawa, M., Kuwahara, A., Yasui, T. & Irahara, M. 2010. Neonatal LPS injection alters the body weight regulation systems of rats under non-stress and immune stress conditions. Int J Dev Neurosci 28, 119-124.
109. Jaaskelainen, A.E., Seppala, S., Kakko, T., Jaakkola, U. & Kallio, J. 2013. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice. Neuropeptides 47, 67-73.
110. Kask, A., Harro, J., von Horsten, S., Redrobe, J.P., Dumont, Y. & Quirion, R. 2002. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26, 259-283.
111. Kawamura, N., Tamura, H., Obana, S., Wenner, M., Ishikawa, T., Nakata, A. & Yamamoto, H. 1998. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. NeuroImmunoModulation 5, 9-15.
112. Kemp, E.H., Waterman, E.A. & Weetman, A.P. 2001. Immunological pathomechanisms in vitiligo. Expert Rev Mol Med 3, 1-22.
113. Kim, Y.W., Kim, K.H., Ahn, D.K., Kim, H.S., Kim, J.Y., Lee, D.C. & Park, S.Y. 2007. Time-course changes of hormones and cytokines by lipopolysaccharide and its relation with anorexia. J Physiol Sci 57, 159-165.
114. Klompus, M., Ho, W., Sharkey, K.A. & McKay, D.M. 2010. Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis. Regul Pept 165, 138-145.
115. Kormos, V. & Gaszner, B. 2013. Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides 47, 401-419.
116. Kuncova, J., Sykora, R., Chvojka, J., Sviglerova, J., Stengl, M., Krouzecky, A., Nalos, L. & Matejovic, M. 2011. Plasma and tissue levels of neuropeptide y in experimental septic shock: relation to hemodynamics, inflammation, oxidative stress, and hemofiltration. Artif Organs 35, 625-633.
117. Kunisada, T., Tezulka, K., Aoki, H. & Motohashi, T. 2014. The stemness of neural crest cells and their derivatives. Birth Defects Res C Embryo Today 102, 251-262.
118. Kuo, L.E., Kitlinska, J.B., Tilan, J.U., Li, L., Baker, S.B., Johnson, M.D., Lee, E.W., Burnett, M.S., Fricke, S.T., Kvetnansky, R., Herzog, H. & Zukowska, Z. 2007. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 13, 803-811.
119. Laddha, N.C., Dwivedi, M., Mansuri, M.S., Singh, M., Patel, H.H., Agarwal, N., Shah, A.M. & Begum, R. 2014. Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility. PLoS One 9, e107020.
120. Larhammar, D. 1996. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide. Regul Pept 65, 165-174.
121. Levite, M. 1998. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 95, 12544-12549.
122. Levite, M., Cahalon, L., Hershkoviz, R., Steinman, L. & Lider, O. 1998. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 160, 993-1000.
123. Li, R., Guan, H. & Yang, K. 2012. Neuropeptide Y potentiates beta-adrenergic stimulation of lipolysis in 3T3-L1 adipocytes. Regul Pept 178, 16-20.
124. Li, Q., Dong, C., Li, W., Bu, W., Wu, J. & Zhao, W. 2014. Neuropeptide Y protects cerebral cortical neurons by regulating microglial immune function. Neural Regen Res 9, 959-967.
125. Lomax, A.E., Sharkey, K.A. & Furness, J.B. 2010. The participation of the sympathetic innervation of the gastrointestinal tract in disease states. Neurogastroenterol Motil 22, 7-18.
126. Lueg, G., Gross, C.C., Lohmann, H., Johnen, A., Kemmling, A., Deppe, M., Groger, J., Minnerup, J., Wiendl, H., Meuth, S.G. & Duning, T. 2015. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease. Neurobiol Aging 36, 81-89.
127. Lundberg, J.M., Rudehill, A., Sollevi, A., Fried, G. & Wallin, G. 1989. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport. Neuroscience 28, 475-486.
128. MacDonald, L., Hazi, A., Paolini, A.G. & Kent, S. 2014. Calorie restriction dose-dependently abates lipopolysaccharide-induced fever, sickness behavior, and circulating interleukin-6 while increasing corticosterone. Brain Behav Immun 40, 18-26.
129. Macia, L., Rao, P.T., Wheway, J., Sierro, F., Mackay, F. & Herzog, H. 2011. Y1 signalling has a critical role in allergic airway inflammation. Immunol Cell Biol 89, 882-888.
130. Macia, L., Thorburn, A.N., Binge, L.C., Marino, E., Rogers, K.E., Maslowski, K.M., Vieira, A.T., Kranich, J. & Mackay, C.R. 2012a. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 245, 164-176.
131. Macia, L., Yulyaningsih, E., Pangon, L., Nguyen, A.D., Lin, S., Shi, Y.C., Zhang, L., Bijker, M., Grey, S., Mackay, F., Herzog, H. & Sainsbury, A. 2012b. Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity. Diabetes 61, 3228-3238.
132. Malva, J.O., Xapelli, S., Baptista, S., Valero, J., Agasse, F., Ferreira, R. & Silva, A.P. 2012. Multifaces of neuropeptide Y in the brain-neuroprotection, neurogenesis and neuroinflammation. Neuropeptides 46, 299-308.
133. McCarthy, H.D., Dryden, S. & Williams, G. 1995. Interleukin-1 beta-induced anorexia and pyrexia in rat: relationship to hypothalamic neuropeptide Y. Am J Physiol 269, E852-E857.
134. McGowan, B.M. & Bloom, S.R. 2004. Peptide YY and appetite control. Curr Opin Pharmacol 4, 583-588.
135. McGuire, J.L., Larke, L.E., Sallee, F.R., Herman, J.P. & Sah, R. 2011. Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress. Front Behav Neurosci 5, 54.
136. McMahon, C.D., Buxton, D.F., Elsasser, T.H., Gunter, D.R., Sanders, L.G., Steele, B.P. & Sartin, J.L. 1999. Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep. J Endocrinol 161, 333-339.
137. McShane, T.M., Wilson, M.E. & Wise, P.M. 1999. Effects of lifelong moderate caloric restriction on levels of neuropeptide Y, proopiomelanocortin, and galanin mRNA. J Gerontol A Biol Sci Med Sci 54, B14-B21.
138. Medina, S., Del Rio, M., Ferrandez, M.D., Hernanz, A. & De la Fuente, M. 1998a. Changes with age in the modulation of natural killer activity of murine leukocytes by gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide. Neuropeptides 32, 549-555.
139. Medina, S., Del Rio, M., Manuel Victor, V., Hernanz, A. & De la Fuente, M. 1998b. Changes with ageing in the modulation of murine lymphocyte chemotaxis by CCK-8S, GRP and NPY. Mech Ageing Dev 102, 249-261.
140. Medina, S., Rio, M.D., Cuadra, B.D., Guayerbas, N. & Fuente, M.D. 1999. Age-related changes in the modulatory action of gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide in the proliferation of murine lymphocytes. Neuropeptides 33, 173-179.
141. Medina, S., Del Rio, M., Hernanz, A. & De la Fuente, M. 2000a. Age-related changes in the neuropeptide Y effects on murine lymphoproliferation and interleukin-2 production. Peptides 21, 1403-1409.
142. Medina, S., Del Rio, M., Hernanz, A. & De la Fuente, M. 2000b. The NPY effects on murine leukocyte adherence and chemotaxis change with age. Adherent cell implication. Regul Pept 95, 35-45.
143. Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. & Westfall, T. 1998. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50, 143-150.
144. Mickey, B.J., Zhou, Z., Heitzeg, M.M., Heinz, E., Hodgkinson, C.A., Hsu, D.T., Langenecker, S.A., Love, T.M., Pecina, M., Shafir, T., Stohler, C.S., Goldman, D. & Zubieta, J.K. 2011. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry 68, 158-166.
145. Mitic, K., Stanojevic, S., Kustrimovic, N., Vujic, V. & Dimitrijevic, M. 2011. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors. Peptides 32, 1626-1633.
146. Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A. & Moser, G. 2004. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 66, 79-84.
147. Molosh, A.I., Sajdyk, T.J., Truitt, W.A., Zhu, W., Oxford, G.S. & Shekhar, A. 2013. NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacology 38, 1352-1364.
148. Morales-Medina, J.C., Dumont, Y. & Quirion, R. 2010. A possible role of neuropeptide Y in depression and stress. Brain Res 1314, 194-205.
149. Morgan, C.A. 3rd, Rasmusson, A.M., Winters, B., Hauger, R.L., Morgan, J., Hazlett, G. & Southwick, S. 2003. Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels. Biol Psychiatry 54, 1087-1091.
150. Morimoto, R., Satoh, F., Murakami, O., Totsune, K., Saruta, M., Suzuki, T., Sasano, H., Ito, S. & Takahashi, K. 2008. Expression of peptide YY in human brain and pituitary tissues. Nutrition 24, 878-884.
151. Murphy, K.G. & Bloom, S.R. 2006. Gut hormones and the regulation of energy homeostasis. Nature 444, 854-859.
152. Myers, A.K., Farhat, M.Y., Vaz, C.A., Keiser, H.R. & Zukowska-Grojec, Z. 1988. Release of immunoreactive-neuropeptide by rat platelets. Biochem Biophys Res Commun 155, 118-122.
153. Nair, M.P., Schwartz, S.A., Wu, K. & Kronfol, Z. 1993. Effect of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav Immun 7, 70-78.
154. Nave, H., Bedoui, S., Moenter, F., Steffens, J., Felies, M., Gebhardt, T., Straub, R.H., Pabst, R., Dimitrijevic, M., Stanojevic, S. & von Horsten, S. 2004. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J Neuroimmunol 155, 1-12.
155. Nishi, D., Hashimoto, K., Noguchi, H. & Matsuoka, Y. 2014. Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder. Neurosci Res 83, 8-12.
156. O'Connor, J.C., Lawson, M.A., Andre, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W. & Dantzer, R. 2009. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Mol Psychiatry 14, 511-522.
157. Pace, T.W., Mletzko, T.C., Alagbe, O., Musselman, D.L., Nemeroff, C.B., Miller, A.H. & Heim, C.M. 2006. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 163, 1630-1633.
158. Painsipp, E., Wultsch, T., Shahbazian, A., Edelsbrunner, M., Kreissl, M.C., Schirbel, A., Bock, E., Pabst, M.A., Thoeringer, C.K., Huber, H.P. & Holzer, P. 2007. Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150, 522-536.
159. Painsipp, E., Herzog, H. & Holzer, P. 2008a. Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice. Neuropharmacology 55, 117-126.
160. Painsipp, E., Wultsch, T., Edelsbrunner, M.E., Tasan, R.O., Singewald, N., Herzog, H. & Holzer, P. 2008b. Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7, 532-542.
161. Painsipp, E., Herzog, H. & Holzer, P. 2010. Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge. J Psychopharmacol 24, 1551-1560.
162. Painsipp, E., Herzog, H., Sperk, G. & Holzer, P. 2011. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y. Br J Pharmacol 163, 1302-1314.
163. Painsipp, E., Kofer, M.J., Farzi, A., Dischinger, U.S., Sinner, F., Herzog, H. & Holzer, P. 2013. Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guerin in mice. Br J Pharmacol 170, 1014-1026.
164. Pang, X.H., Li, T.K., Xie, Q., He, F.Q., de Cui, J., Chen, Y.Q., Huang, X.L. & Gan, H.T. 2010. Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Int J Colorectal Dis 25, 1047-1053.
165. Parihar, V.K., Hattiangady, B., Kuruba, R., Shuai, B. & Shetty, A.K. 2011. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol Psychiatry 16, 171-183.
166. Persaud, S.J. & Bewick, G.A. 2014. Peptide YY: more than just an appetite regulator. Diabetologia 57, 1762-1769.
167. Petitto, J.M., Huang, Z. & McCarthy, D.B. 1994. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J Neuroimmunol 54, 81-86.
168. Phan, T.A. & Taylor, A.W. 2013. The neuropeptides alpha-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells. J Neuroimmunol 260, 9-16.
169. Pidsudko, Z., Wasowicz, K., Kaleczyc, J., Klimczuk, M., Bossowska, A., Majewski, M., Adriaensen, D. & Timmermans, J.P. 2011. The influence of ileitis on the neurochemistry of the caudal mesenteric ganglion in the pig. Neurogastroenterol Motil 23, e213-e222.
170. Puerto, M., Guayerbas, N., Alvarez, P. & De la Fuente, M. 2005. Modulation of neuropeptide Y and norepinephrine on several leucocyte functions in adult, old and very old mice. J Neuroimmunol 165, 33-40.
171. Radler, M.E., Wright, B.J., Walker, F.R., Hale, M.W. & Kent, S. 2014. Calorie restriction increases lipopolysaccharide-induced neuropeptide Y immunolabeling and reduces microglial cell area in the arcuate hypothalamic nucleus. Neuroscience 285C, 236-247.
172. Rasmusson, A.M., Hauger, R.L., Morgan, C.A., Bremner, J.D., Charney, D.S. & Southwick, S.M. 2000. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 47, 526-539.
173. Redrobe, J.P., Carvajal, C., Kask, A., Dumont, Y. & Quirion, R. 2004a. Neuropeptide Y and Its Receptor Subtypes in the Central Nervous System: emphasis on Their Role in Animal Models of Psychiatric Disorders. In: Handbook of Experimental Pharmacology, Vol. 162, pp. 101-136. Springer, Berlin, Heidelberg.
174. Redrobe, J.P., Dumont, Y., Herzog, H. & Quirion, R. 2004b. Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci 22, 159-166.
175. Romano, T.A., Felten, S.Y., Felten, D.L. & Olschowka, J.A. 1991. Neuropeptide-Y innervation of the rat spleen: another potential immunomodulatory neuropeptide. Brain Behav Immun 5, 116-131.
176. Rosmaninho-Salgado, J., Alvaro, A.R., Grouzmann, E., Duarte, E.P. & Cavadas, C. 2007. Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells. Peptides 28, 310-314.
177. Sah, R. & Geracioti, T.D. 2013. Neuropeptide Y and posttraumatic stress disorder. Mol Psychiatry 18, 646-655.
178. Sah, R., Ekhator, N.N., Strawn, J.R., Sallee, F.R., Baker, D.G., Horn, P.S. & Geracioti, T.D. Jr 2009. Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry 66, 705-707.
179. Sah, R., Ekhator, N.N., Jefferson-Wilson, L., Horn, P.S. & Geracioti, T.D. Jr 2014. Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology 40, 277-283.
180. Sajdyk, T.J., Schober, D.A., Gehlert, D.R. & Shekhar, A. 1999a. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100, 207-215.
181. Sajdyk, T.J., Vandergriff, M.G. & Gehlert, D.R. 1999b. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368, 143-147.
182. Sajdyk, T.J., Shekhar, A. & Gehlert, D.R. 2004. Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38, 225-234.
183. Sajdyk, T.J., Fitz, S.D. & Shekhar, A. 2006. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 9, 21-28.
184. Sajdyk, T.J., Johnson, P.L., Leitermann, R.J., Fitz, S.D., Dietrich, A., Morin, M., Gehlert, D.R., Urban, J.H. & Shekhar, A. 2008. Neuropeptide Y in the amygdala induces long-term resilience to stress-induced reductions in social responses but not hypothalamic-adrenal-pituitary axis activity or hyperthermia. J Neurosci 28, 893-903.
185. Sam, A.H., Gunner, D.J., King, A., Persaud, S.J., Brooks, L., Hostomska, K., Ford, H.E., Liu, B., Ghatei, M.A., Bloom, S.R. & Bewick, G.A. 2012. Selective ablation of peptide YY cells in adult mice reveals their role in beta cell survival. Gastroenterology 143, 459-468.
186. Samuel, B.S., Shaito, A., Motoike, T., Rey, F.E., Backhed, F., Manchester, J.K., Hammer, R.E., Williams, S.C., Crowley, J., Yanagisawa, M. & Gordon, J.I. 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 105, 16767-16772.
187. Saria, A. & Beubler, E. 1985. Neuropeptide Y (NPY) and peptide YY (PYY) inhibit prostaglandin E2-induced intestinal fluid and electrolyte secretion in the rat jejunum in vivo. Eur J Pharmacol 119, 47-52.
188. Saurer, T.B., Ijames, S.G. & Lysle, D.T. 2006. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity. J Neuroimmunol 177, 18-26.
189. Schele, E., Grahnemo, L., Anesten, F., Hallen, A., Backhed, F. & Jansson, J.O. 2013. The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system. Endocrinology 154, 3643-3651.
190. Schicho, R., Schemann, M., Pabst, M.A., Holzer, P. & Lippe, I.T. 2003. Capsaicin-sensitive extrinsic afferents are involved in acid-induced activation of distinct myenteric neurons in the rat stomach. Neurogastroenterol Motil 15, 33-44.
191. Schmidt, P.T., Ljung, T., Hartmann, B., Hare, K.J., Holst, J.J. & Hellstrom, P.M. 2005. Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 17, 207-212.
192. Schwarz, H., Villiger, P.M., von Kempis, J. & Lotz, M. 1994. Neuropeptide Y is an inducible gene in the human immune system. J Neuroimmunol 51, 53-61.
193. Serova, L.I., Tillinger, A., Alaluf, L.G., Laukova, M., Keegan, K. & Sabban, E.L. 2013. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats. Neuroscience 236, 298-312.
194. Serova, L.I., Laukova, M., Alaluf, L.G., Pucillo, L. & Sabban, E.L. 2014. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model. Eur Neuropsychopharmacol 24, 142-147.
195. Shibata, M., Hisajima, T., Nakano, M., Goris, R.C. & Funakoshi, K. 2008. Morphological relationships between peptidergic nerve fibers and immunoglobulin A-producing lymphocytes in the mouse intestine. Brain Behav Immun 22, 158-166.
196. Silva, A.P., Cavadas, C., Baisse-Agushi, B., Spertini, O., Brunner, H.R. & Grouzmann, E. 2003. NPY, NPY receptors, and DPP IV activity are modulated by LPS, TNF-alpha and IFN-gamma in HUVEC. Regul Pept 116, 71-79.
197. Singer, K., Morris, D.L., Oatmen, K.E., Wang, T., DelProposto, J., Mergian, T., Cho, K.W. & Lumeng, C.N. 2013. Neuropeptide Y is produced by adipose tissue macrophages and regulates obesity-induced inflammation. PLoS One 8, e57929.
198. Smith, P.M., Howitt, M.R., Panikov, N., Michaud, M., Gallini, C.A., Bohlooly-Y, M., Glickman, J.N. & Garrett, W.S. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573.
199. Sonti, G., Ilyin, S.E. & Plata-Salaman, C.R. 1996. Neuropeptide Y blocks and reverses interleukin-1 beta-induced anorexia in rats. Peptides 17, 517-520.
200. Stadlbauer, U., Langhans, W. & Meyer, U. 2013. Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia. Neuropsychopharmacology 38, 2446-2455.
201. 13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels. Ann Anat 193, 486-493.
202. Stanojevic, S., Vujic, V., Kovacevic-Jovanovic, V., Mitic, K., Kosec, D., Horsten, S. & Dimitrijevic, M. 2006. Age-related effect of peptide YY (PYY) on paw edema in the rat: the function of Y1 receptors on inflammatory cells. Exp Gerontol 41, 793-799.
203. Stogner, K.A. & Holmes, P.V. 2000. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacol 387, R9-R10.
204. Straub, R.H., Mayer, M., Kreutz, M., Leeb, S., Scholmerich, J. & Falk, W. 2000a. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67, 553-558.
205. Straub, R.H., Schaller, T., Miller, L.E., von Horsten, S., Jessop, D.S., Falk, W. & Scholmerich, J. 2000b. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J Neurochem 75, 2464-2471.
206. Straub, R.H., Herfarth, H., Falk, W., Andus, T. & Scholmerich, J. 2002. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol 126, 116-125.
207. Sung, C.P., Arleth, A.J. & Feuerstein, G.Z. 1991. Neuropeptide Y upregulates the adhesiveness of human endothelial cells for leukocytes. Circ Res 68, 314-318.
208. Tari, A., Teshima, H., Sumii, K., Haruma, K., Ohgoshi, H., Yoshihara, M., Kajiyama, G. & Miyachi, Y. 1988. Peptide YY abnormalities in patients with ulcerative colitis. Jpn J Med 27, 49-55.
209. Tasan, R.O., Lin, S., Hetzenauer, A., Singewald, N., Herzog, H. & Sperk, G. 2009. Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158, 1717-1730.
210. Tasan, R.O., Nguyen, N.K., Weger, S., Sartori, S.B., Singewald, N., Heilbronn, R., Herzog, H. & Sperk, G. 2010. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 30, 6282-6290.
211. Taylor, B.K., Fu, W., Kuphal, K.E., Stiller, C.O., Winter, M.K., Chen, W., Corder, G.F., Urban, J.H., McCarson, K.E. & Marvizon, J.C. 2014. Inflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons. Neuroscience 256, 178-194.
212. Tazoe, H., Otomo, Y., Kaji, I., Tanaka, R., Karaki, S.I. & Kuwahara, A. 2008. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59(Suppl 2), 251-262.
213. Thiriet, N., Deng, X., Solinas, M., Ladenheim, B., Curtis, W., Goldberg, S.R., Palmiter, R.D. & Cadet, J.L. 2005. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25, 5273-5279.
214. Thorsell, A., Svensson, P., Wiklund, L., Sommer, W., Ekman, R. & Heilig, M. 1998. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept 75-76, 247-254.
215. Thorsell, A., Carlsson, K., Ekman, R. & Heilig, M. 1999. Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress. NeuroReport 10, 3003-3007.
216. Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathe, A.A. & Heilig, M. 2000. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97, 12852-12857.
217. Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H. & Sperk, G. 2003. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18, 143-148.
218. Tu, C., Zhao, D. & Lin, X. 2001. Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo. J Dermatol Sci 27, 178-182.
219. Ueno, H., Yamaguchi, H., Mizuta, M. & Nakazato, M. 2008. The role of PYY in feeding regulation. Regul Pept 145, 12-16.
220. Upchurch, B.H., Aponte, G.W. & Leiter, A.B. 1994. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120, 245-252.
221. Van Citters, G.W. & Lin, H.C. 2006. Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8, 367-373.
222. Van Pett, K., Viau, V., Bittencourt, J.C., Chan, R.K., Li, H.Y., Arias, C., Prins, G.S., Perrin, M., Vale, W. & Sawchenko, P.E. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428, 191-212.
223. Vona-Davis, L. & McFadden, D.W. 2007. PYY and the pancreas: inhibition of tumor growth and inflammation. Peptides 28, 334-338.
224. Wang, L., Gourcerol, G., Yuan, P.Q., Wu, S.V., Million, M., Larauche, M. & Tache, Y. 2010. Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice. Am J Physiol Gastrointest Liver Physiol 298, G45-G56.
225. Wettstein, J.G., Earley, B. & Junien, J.L. 1995. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65, 397-414.
226. Wheway, J., Mackay, C.R., Newton, R.A., Sainsbury, A., Boey, D., Herzog, H. & Mackay, F. 2005. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202, 1527-1538.
227. Wheway, J., Herzog, H. & Mackay, F. 2007a. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 7, 1743-1752.
228. Wheway, J., Herzog, H. & Mackay, F. 2007b. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides 28, 453-458.
229. Yang, K., Guan, H., Arany, E., Hill, D.J. & Cao, X. 2008. Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor. FASEB J 22, 2452-2464.
230. Yehuda, R., Brand, S. & Yang, R.K. 2006. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 59, 660-663.
231. Zhang, L., Nguyen, A.D., Lee, I.C., Yulyaningsih, E., Riepler, S.J., Stehrer, B., Enriquez, R.F., Lin, S., Shi, Y.C., Baldock, P.A., Sainsbury, A. & Herzog, H. 2012. NPY modulates PYY function in the regulation of energy balance and glucose homeostasis. Diabetes Obes Metab 14, 727-736.
232. Zhang, W., Cline, M.A. & Gilbert, E.R. 2014. Hypothalamus-adipose tissue crosstalk: neuropeptide Y and the regulation of energy metabolism. Nutr Metab (Lond) 11, 27. eCollection 2014.
233. Zhou, J.R., Xu, Z. & Jiang, C.L. 2008a. Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor. Neurosci Bull 24, 155-159.
234. Zhou, Z., Zhu, G., Hariri, A.R., Enoch, M.A., Scott, D., Sinha, R., Virkkunen, M., Mash, D.C., Lipsky, R.H., Hu, X.Z., et al. 2008b. Genetic variation in human NPY expression affects stress response and emotion. Nature 452, 997-1001.
235. Zhou, J.R., Zhang, L.D., Wei, H.F., Wang, X., Ni, H.L., Yang, F., Zhang, T. & Jiang, C.L. 2013. Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway. J Neuroimmunol 260, 55-59.